Corrigendum to “Pulmonary Delivery of siRNA Lipoplexes and Lipid Nanoparticles using a Vibrating Mesh Nebuliser” [European Journal of Pharmaceutical Sciences 107386 216(2026)]
M Neary(University College Cork), Katie B. Ryan(University College Cork), Abina M. Crean(University College Cork), Lianne M. Mulder(University College Cork), Piotr S. Kowalski(Massachusetts Institute of Technology), Łukasz Baranowski(International Institute of Molecular and Cell Biology), Ronan MacLoughlin(Aerogen (Ireland)), Ciaran O. Leime(Aerogen (Ireland)), Brunella Grassiri(Trinity College Dublin)
Cited by 0
Related Papers
Magnetic core-shell nanoparticles for drug delivery by nebulization
|Journal of Nanobiotechnology|2013|257
Mesoporous silica formulation strategies for drug dissolution enhancement: a review
|Expert Opinion on Drug Delivery|2015|190
Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy
|Journal of Clinical Investigation|2017|170
Comparison of fenofibrate–mesoporous silica drug-loading processes for enhanced drug delivery
|European Journal of Pharmaceutical Sciences|2013|117
Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications
|Cellular and Molecular Life Sciences|2011|111